Hematotoxicological analysis of surface‐modified and ‐unmodified chitosan nanoparticles
Tóm tắt
The increasing interest in using chitosan nanoparticles for controlled drug delivery is hampered by its blood incompatibility, especially for intravenous applications. This study investigated the effects of processing solvents (acetic acid/lactic acid), dispersing media (acidic medium/saline), and surface modifiers (polyethylene glycol, polyvinyl alcohol, and ethylenediaminetetraacetatic acid) on the hemocompatibility of chitosan. Blood compatibility of chitosan nanoparticles prepared by ionotropic gelation with altered surface chemistry was evaluated by assessing their hemolytic activity, platelet aggregation, coagulation, and cytokine induction. It was observed that nanoparticles prepared in lactic acid and dispersed in saline did not show hemolysis, platelet aggregation, or coagulation, whereas nanoparticles prepared in acetic acid showed strong hemolysis. Surface modifiers were not observed to significantly affect blood compatibility, with the exception of EDTA, which delayed blood clotting times. Thus, chitosan nanoparticles prepared in lactic acid and dispersed in saline may be an ideal nanocarrier for parenteral applications. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:2957–2966, 2013.
Từ khóa
Tài liệu tham khảo
Muzzarelli RAA, 1989, Amphoteric derivatives of chitosan and their biological significance, in Chitin and Chitosan, 87
Patel JK, 2009, Chitosan based nanoparticles in drug delivery, Int J Pharm Sci Nanotechnol, 2, 517
Zohri M, 2009, Polymeric nanoparticles: Production, applications and advantage, Int J Nanotechnol, 3, 1937
Brandenberg G, 1984, Chitosan: A new topical hemostatic agent for diffuse capillary bleeding in brain tissue, Neurosurgery, 15, 9, 10.1227/00006123-198407000-00004
Radhakumary C, 2005, Biopolymer composite of chitosan and methyl methacrylate for medical applications, Trends Biomater Artif Organs, 18, 117
Li‐Feng Q, 2005, In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells, World J Gastroenterol, 11, 5136